Table 2.
Susceptibility to CHG among clinical isolates.
| Characteristic | MSSA n = 98 n (%) |
MRSA n = 92 n (%) |
Total Isolates n = 190 n |
p-Value 1 |
|---|---|---|---|---|
| Reduced susceptibility to CHG | <0.001 2 | |||
| Yes | 3 (12) | 22 (88) | 25 | |
| No | 95 (57.6) | 70 (42.4) | 165 | |
| CHG’s MIC (mg/L) | <0.001 | |||
| Mean | 1.62 | 2.5 | 2.04 | |
| Median (Q1, Q3) | 2 (1, 2) | 2 (2, 3.5) | 2 (1, 2) | |
| CHG’s MBC (mg/L) | <0.035 | |||
| Mean | 2.23 | 2.45 | 2.33 | |
| Median (Q1, Q3) | 2 (1, 2) | 2 (2, 2) | 2 (2, 2) | |
| qac A/B presence | <0.001 | |||
| Yes | 4 (16) | 21 (84) | 25 | |
| No | 94 (57) | 71 (43) | 165 |
1 Chi-squared test, Mann–Whitney test. 2 Bold values indicate statistical significance.